SpassageQ
Multivariate Vital Signs Index. 510(k) K230386, from Spass, Inc. (Seoul, KR). Product code PLB, class 2.
As of Nov 19, 2026, K230386 is an FDA 510(k) held by Spass, Inc., substantially equivalent on Jun 15, 2023 after 121 days, with no recalls tied to it in FDA's recall database.
- Review time: 121 days
- Recalls: 0
- Cited as a predicate by: 1 device
The SpassageQ is intended to be used with patient data from already cleared patient monitoring devices which measure respiratory rate, systolic blood pressure, and Glasgow Coma Scale (GCS) in patients being monitored in a healthcare facility. The device provides qSOFA score (also known as quickSOFA) which indicates patients with suspected infection who are at greater risk for a poor outcome.
- Biovitals Analytics EngineK183282 · Biofourmis Singapore Pte., Ltd. · Aug 15, 2019
- NavoycdsK240558 · Algodx AB · Jul 22, 2024
- Aitrics-VcK240756 · Aitrics Co., Ltd. · Jul 23, 2024
- NavoycdsK240558 · Algodx AB · Jul 22, 2024
- T3 Platform softwareK213423 · Etiometry, Inc. · Jan 6, 2023
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Feb 14, 2023
- Review panel
- Cardiovascular
- Regulation
- 21 CFR 870.2300
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files